Related Experiment Video
Updated: Mar 30, 2026

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
Published on: January 22, 2019
PML/TRIM19-Dependent Inhibition of Retroviral Reverse-Transcription by Daxx
Jacques Dutrieux1, Ghizlane Maarifi1, Débora M Portilho2
1Paris Descartes University, Paris, France.
Abstract:
PML (Promyelocytic Leukemia protein), also known as TRIM19, belongs to the family of tripartite motif (TRIM) proteins. PML is mainly expressed in the nucleus, where it forms dynamic structures known as PML nuclear bodies that recruit many other proteins, such as Sp100 and Daxx. While the role of PML/TRIM19 in antiviral defense is well documented, its effect on HIV-1 infection remains unclear. Here we show that infection by HIV-1 and other retroviruses triggers the formation of PML cytoplasmic bodies, as early as 30 minutes post-infection. Quantification of the number and size of PML cytoplasmic bodies revealed that they last approximately 8 h, with a peak at 2 h post-infection. PML re-localization is blocked by reverse-transcription inhibitors and is not observed following infection with unrelated viruses, suggesting it is specifically triggered by retroviral reverse-transcription. Furthermore, we show that PML interferes with an early step of retroviral infection since PML knockdown dramatically increases reverse-transcription efficiency. We demonstrate that PML does not inhibit directly retroviral infection but acts through the stabilization of one of its well-characterized partners, Daxx. In the presence of PML, cytoplasmic Daxx is found in the vicinity of incoming HIV-1 capsids and inhibits reverse-transcription. Interestingly, Daxx not only interferes with exogenous retroviral infections but can also inhibit retrotransposition of endogenous retroviruses, thus identifying Daxx as a broad cellular inhibitor of reverse-transcription. Altogether, these findings unravel a novel antiviral function for PML and PML nuclear body-associated protein Daxx.
Insights
Promyelocytic Leukemia protein (PML) forms cytoplasmic bodies during HIV-1 infection, inhibiting viral reverse-transcription through its partner Daxx. This reveals a novel antiviral role for PML and Daxx against retroviruses.
Area of Science:
- Cell Biology
- Virology
- Molecular Biology
Background:
- Promyelocytic Leukemia protein (PML), also known as TRIM19, is a nuclear protein forming PML nuclear bodies.
- The antiviral role of PML is known, but its specific impact on HIV-1 infection is unclear.
Purpose of the Study:
- To investigate the effect of HIV-1 infection on PML localization and function.
- To elucidate the mechanism by which PML influences retroviral infection.
Main Methods:
- Monitoring PML localization and PML cytoplasmic body formation post-HIV-1 infection.
- Using reverse-transcription inhibitors to study PML re-localization triggers.
- Performing PML knockdown experiments to assess its impact on reverse-transcription efficiency.
- Investigating the interaction between PML, Daxx, and HIV-1 components.
Main Results:
- HIV-1 infection triggers the formation of PML cytoplasmic bodies within 30 minutes, peaking at 2 hours and lasting for 8 hours.
- PML re-localization is specifically dependent on retroviral reverse-transcription.
- PML knockdown enhances HIV-1 reverse-transcription efficiency, indicating an inhibitory role.
- PML inhibits retroviral infection by stabilizing cytoplasmic Daxx, which then interferes with reverse-transcription near incoming HIV-1 capsids.
- Daxx demonstrates broad inhibitory activity against both exogenous and endogenous retroviruses.
Conclusions:
- PML exhibits a novel antiviral function against HIV-1 by promoting the formation of cytoplasmic bodies.
- PML-mediated inhibition of retroviral reverse-transcription is dependent on the stabilization of its partner protein, Daxx.
- Daxx acts as a broad cellular inhibitor of reverse-transcription, impacting both exogenous and endogenous retroviruses.
More Related Videos
05:55Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
13:07Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells
Published on: January 30, 2019
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Retroviruses
Inhibition of CDK Activity
Inhibition of Cdk Activity
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...